Company intelligence / Profile preview

C&O Pharmaceutical Technology (Holdings) Limited

Tsim Sha Tsui, Kowloon, Hong Kong

Ownership: Private
Development stage: Other

Overview

C&O Pharmaceutical Technology (Holdings) Limited, founded in 1997, is a pharmaceutical company focusing on the R&D, manufacturing, and sales of generic drugs in China. It was acquired by Shionogi & Co., Ltd. in 2011 and subsequently merged into Shionogi China Co., Ltd. in 2021, operating as its generic drug business segment. The company specializes in branded and exclusive products, including Amoxycillin Capsules, across various therapeutic areas.

Industry: Biotech

Drug pipeline

1 asset

metakavir

Unknown

Partnerships

Shionogi & Co., Ltd.Sumitomo Corporation

Beyond the preview

Go deeper on C&O Pharmaceutical Technology (Holdings) Limited.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on C&O Pharmaceutical Technology (Holdings) Limited.

Explore the full profile